174
Views
35
CrossRef citations to date
0
Altmetric
Original Research

Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects

, , , , , & show all
Pages 1789-1804 | Published online: 08 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Bingqian Li, Huili Shao, Lei Gao, Huan Li, Huagang Sheng & Liqiao Zhu. (2022) Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Delivery 29:1, pages 2130-2161.
Read now
Rania F. Ahmed, Maha Nasr, Marawan Abd Elbaset, Alyaa Farouk Hessin, Omar A. H. Ahmed-Farid, Nermeen M. Shaffie & Marwa E. Shabana. (2022) Combating hematopoietic and hepatocellular abnormalities resulting from administration of cisplatin: role of liver targeted glycyrrhetinic acid nanoliposomes loaded with amino acids. Pharmaceutical Development and Technology 27:9, pages 925-941.
Read now
Yanying Li, Jingliang Wu, Qiao Lu, Xuemin Liu, Jiaxuan Wen, Xiaohui Qi, Jianhao Liu, Bo Lian, Bo Zhang, Hengyi Sun & Guixiang Tian. (2022) GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma. International Journal of Nanomedicine 17, pages 2559-2575.
Read now
Fangqing Wang, Yanying Li, Hong Jiang, Chenglei Li, Zhaohuan Li, Cuiping Qi, Zhipeng Li, Zhiqin Gao, Bo Zhang & Jingliang Wu. (2021) Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis. International Journal of Nanomedicine 16, pages 4001-4016.
Read now
Bo Lian, Hua Wei, Ruiyan Pan, Jingui Sun, Bo Zhang, Jingliang Wu, Xiujie Li & Guixiang Tian. (2021) Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4. International Journal of Nanomedicine 16, pages 457-467.
Read now
Xuwang Pan, Shourong Liu, Liping Ju, Jianjun Xi, Ruoyu He, Yanmei Zhao, Rangxiao Zhuang & Jinsong Huang. (2020) Preparation, evaluation, and in vitro cytotoxicity studies of artesunate-loaded glycyrrhetinic acid decorated PEG-PLGA nanoparticles. Drug Development and Industrial Pharmacy 46:11, pages 1889-1897.
Read now

Articles from other publishers (29)

Mingxing Qiu, Jiong Wang, Jiaojiao Bai, Xiaoxu Li, Cuiqing Tian, Zhi Liu, Chaoran Zheng, Andrew R. Clark, Xinwei Cheng, Xiaoyan Liao, Song Wu, Robert J. Lee & Xiaoju Zhou. (2023) Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy. Molecular Pharmaceutics 20:4, pages 1951-1963.
Crossref
Sulieman Ibraheem Shelash Al‐Hawary, Saade Abdalkareem Jasim, Mustafa M. Kadhim, Sarah Jaafar Saadoon, Irfan Ahmad, Rosario Mireya Romero Parra, Suzan Hasan Hammoodi, Roua Abulkassim, Noora M. Hameed, Waleed K. Alkhafaje, Yasser Fakri Mustafa & Mohammad Javed Ansari. (2023) Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations. Phytotherapy Research 37:4, pages 1624-1639.
Crossref
Girish Kumar, Tarun Virmani, Ashwani Sharma & Kamla Pathak. (2023) Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers. Pharmaceutics 15:3, pages 889.
Crossref
Jingliang Wu, Cuiping Qi, Taotao Xu, Qingyun Zhang, Feifei Liu, Huifang Zhao, Jinping Dong & Xuemin Liu. (2023) Mixed Nanoscale Liposomes Co-Encapsulating Curcumin and Berberine Inhibit Activated Hepatic Stellate Cell-Induced Drug Resistance and Tumor Metastasis. ACS Applied Nano Materials 6:3, pages 1796-1807.
Crossref
Chenyu Zhang, Xiang Li, Zhenjian Xing, Honglan Zhong, Dianbao Yu, Rui Yu & Xin Deng. (2023) Plasma metabolites-based design of long-acting peptides and their anticancer evaluation. International Journal of Pharmaceutics 631, pages 122483.
Crossref
Linjun Zou, Qinglong Li, Yong Hou, Meiying Chen, Xudong Xu, Haifeng Wu, Zhaocui Sun & Guoxu Ma. (2022) Self-assembled glycyrrhetinic acid derivatives for functional applications: a review. Food & Function 13:24, pages 12487-12509.
Crossref
Jingliang Wu, Fangqing Wang, Jinping Dong, Suqiu Zhang, Na Li, Huifang Zhao, Xuemin Liu, Zhiqin Gao, Bo Zhang & Guixiang Tian. (2022) Therapeutic Response of Multifunctional Lipid and Micelle Formulation in Hepatocellular Carcinoma. ACS Applied Materials & Interfaces 14:40, pages 45110-45123.
Crossref
Cuc Thi Dinh, Ha Thi Vu, Quynh Thi Huong Phan, Linh Phuong Nguyen, Toan Quoc Tran, Dung Van Tran, Nguyen Ngoc Quy, Dung Thuy Nguyen Pham & Duong Thanh Nguyen. (2022) Synthesis of glycyrrhetinic acid-modified liposomes to deliver Murrayafoline A for treatment of hepatocellular carcinoma. Journal of Materials Science: Materials in Medicine 33:10.
Crossref
Jingliang Wu, Cuiping Qi, Hao Wang, Qing Wang, Jingui Sun, Jinping Dong, Guohua Yu, Zhiqin Gao, Bo Zhang & Guixiang Tian. (2022) Curcumin and berberine co-loaded liposomes for anti-hepatocellular carcinoma therapy by blocking the cross-talk between hepatic stellate cells and tumor cells. Frontiers in Pharmacology 13.
Crossref
Adrian Bartos, Ioana Iancu, Lidia Ciobanu, Anca Onaciu, Cristian Moldovan, Alin Moldovan, Radu Cristian Moldovan, Adrian Bogdan Tigu, Gabriela Fabiola Stiufiuc, Valentin Toma, Cornel Iancu, Nadim Al Hajjar & Rares Ionut Stiufiuc. (2022) Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study. Nanomaterials 12:16, pages 2833.
Crossref
Xue Gong, Jingliang Wu, Jiaxuan Wen, Xueying Ding, Na Xu, Mengmeng Sun, Guohua Yu, Shuzhen Liu, Bo Zhang & Hongying Liu. (2022) Dual-Ligand-Modified Nanoscale Liposomes Loaded with Curcumin and Metformin Inhibit Drug Resistance and Metastasis of Hepatocellular Carcinoma. ACS Applied Nano Materials 5:5, pages 7063-7077.
Crossref
Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, Mariateresa Cristani, Francesco Cimino & Antonella Saija. (2022) Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy. Molecules 27:6, pages 1775.
Crossref
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi & Mahmoud Teaima. (2022) Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. Journal of Nanobiotechnology 20:1.
Crossref
Zonghua Tian, Yue Zhao, Yaping Mai, Fangxia Qiao, Jueshuo Guo, Luning Dong, Yang Niu, Guojing Gou & Jianhong Yang. (2022) Nanocrystals with different stabilizers overcome the mucus and epithelial barriers for oral delivery of multicomponent Bufadienolides. International Journal of Pharmaceutics 616, pages 121522.
Crossref
Manish Kumar, Abhishek Jha, Kanchan Bharti & Brahmeshwar Mishra. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery 201 217 .
Luciano A. Stecanella, Antonio P. R. Bitencourt, Gustavo Richter Vaz, Eride Quarta, José O. C. Silva Júnior & Alessandra Rossi. (2021) Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer. Pharmaceutics 13:11, pages 1792.
Crossref
Antonia Charalambous, Victoria Mico, Laura E. McVeigh, Gemma Marston, Nicola Ingram, Milène Volpato, Sally A. Peyman, James R. McLaughlan, Antonia Wierzbicki, Paul M. Loadman, Richard J. Bushby, Alexander F. Markham, Stephen D. Evans & P. Louise Coletta. (2021) Targeted microbubbles carrying lipid-oil-nanodroplets for ultrasound-triggered delivery of the hydrophobic drug, combretastatin A4. Nanomedicine: Nanotechnology, Biology and Medicine 36, pages 102401.
Crossref
Cuiping Qi, Di Wang, Xue Gong, Qiyang Zhou, Xinxin Yue, Chenglei Li, Zhipeng Li, Guixiang Tian, Bo Zhang, Qing Wang, Xiuhong Wei & Jingliang Wu. (2021) Co-Delivery of Curcumin and Capsaicin by Dual-Targeting Liposomes for Inhibition of aHSC-Induced Drug Resistance and Metastasis. ACS Applied Materials & Interfaces 13:14, pages 16019-16035.
Crossref
Ali Zarrabi, Atefeh Zarepour, Arezoo Khosravi, Zahra Alimohammadi & Vijay Kumar Thakur. (2021) Synthesis of Curcumin Loaded Smart pH-Responsive Stealth Liposome as a Novel Nanocarrier for Cancer Treatment. Fibers 9:3, pages 19.
Crossref
Reem Abou Assi, Ibrahim M. Abdulbaqi & Chan Siok Yee. (2021) The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. Pharmaceuticals 14:3, pages 215.
Crossref
Yu-Lan Li, Xiao-Min Zhu, Hong Liang, Chris Orvig & Zhen-Feng Chen. (2021) Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery. Current Medicinal Chemistry 28:8, pages 1508-1534.
Crossref
Ankita Tiwari & Sanjay K. Jain. (2020) Curcumin Based Drug Delivery Systems for Cancer Therapy. Current Pharmaceutical Design 26:42, pages 5430-5440.
Crossref
Desu N.K. Reddy, Fu-Yung Huang, Shao-Pin Wang & Ramya Kumar. (2020) Synergistic Antioxidant and Antibacterial Activity of Curcumin-C3 Encapsulated Chitosan Nanoparticles. Current Pharmaceutical Design 26:39, pages 5021-5029.
Crossref
Nemany A.N. Hanafy, Stefano Leporatti & Maged El-Kemary. (2020) Mucoadhesive curcumin crosslinked carboxy methyl cellulose might increase inhibitory efficiency for liver cancer treatment. Materials Science and Engineering: C 116, pages 111119.
Crossref
Xiaocheng Li, Wenbin Diao, Hantao Xue, Fei Wu, Weiyu Wang, Bin Jiang, Jingkun Bai, Bo Lian, Weiguo Feng, Tongyi Sun, Wenjing Yu, Jingliang Wu, Meihua Qu, Yubing Wang & Zhiqin Gao. (2020) Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma. Cancer Letters 489, pages 163-173.
Crossref
Kun Zhu, Lili Zhou, Manshu Zou, Shuangcheng Ning, Shulan Liu, Yilin Zhou, Ke Du, Xiaoqing Zhang & Xinhua Xia. (2020) 18-GA-Suc Modified Liposome Loading Cantharidin for Augmenting Hepatic Specificity: Preparation, Characterization, Antitumor Effects, and Liver-Targeting Efficiency. Journal of Pharmaceutical Sciences 109:6, pages 2038-2047.
Crossref
Caroline J. Thébault, Grégory Ramniceanu, Sarah Boumati, Aude Michel, Johanne Seguin, Benoit Larrat, Nathalie Mignet, Christine Ménager & Bich-Thuy Doan. (2020) Theranostic MRI liposomes for magnetic targeting and ultrasound triggered release of the antivascular CA4P. Journal of Controlled Release 322, pages 137-148.
Crossref
Gökçe Şeker Karatoprak, Esra Küpeli Akkol, Yasin Genç, Hilal Bardakcı, Çiğdem Yücel & Eduardo Sobarzo-Sánchez. (2020) Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications. Molecules 25:11, pages 2560.
Crossref
Dapeng Chen, Xinyu Qu, Jinjun Shao, Wenjun Wang & Xiaochen Dong. (2020) Anti-vascular nano agents: a promising approach for cancer treatment. Journal of Materials Chemistry B 8:15, pages 2990-3004.
Crossref